ANXA5 and neoplasm: To test this possibility, we first incubated tumor‐specific CD8+ T cells with tumor cells at various E:T ratios for 48 h and tested the tumor‐killing ability of tumor‐specific CD8+ T cells using Annexin V/PI staining and lactate dehydrogenase (LDH) assay.